Breast cancer is a heterogeneous disease, classified largely by the expression of the estrogen receptor (ER), progesterone receptor (PR), and by amplification of the human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene PGR and breast carcinoma.